Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

Enrolling by invitationOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

March 1, 2025

Study Completion Date

January 31, 2026

Conditions
Breast Cancer DiagnosisBreast Cancer Prevention
Interventions
DIAGNOSTIC_TEST

Contrast-Enhanced Mammography (CEM)

"The intervention in this study involves Contrast-Enhanced Mammography (CEM), a specialized imaging technique that combines standard mammography with contrast-enhanced imaging to detect neo-angiogenesis, which is a characteristic of malignancy. Unlike traditional mammography, CEM utilizes both low-energy and high-energy images to provide enhanced visualization of tissue vascularity, aiding in the identification of occult primary tumors, particularly in patients with Cancer of Unknown Primary (CUP) syndrome.~Patients who present with CUP syndrome, suspected of having a primary breast malignancy, will undergo CEM as part of their diagnostic workup. The CEM findings will be compared with other conventional imaging modalities, including ultrasound and MRI, to assess the diagnostic accuracy of CEM in detecting primary breast tumors. The intervention will also involve correlating the imaging results with histopathological findings from biopsy or surgical specimens.~This study aims to demons"

Trial Locations (1)

80138

Link Campus University, Rome

All Listed Sponsors
collaborator

Link Campus University

OTHER

collaborator

University of Campania Luigi Vanvitelli

OTHER

lead

Graziella di Grezia

OTHER